PSYCHEMEDICS CORP shareholders Q3 2023

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

PSYCHEMEDICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
22NW, LP 274,418$1,089,4390.78%
WEALTH EFFECTS LLC 40,701$161,5820.08%
Cannell Capital 74,794$296,9320.07%
SANTA MONICA PARTNERS LP 20,000$790.06%
RBF Capital, LLC 144,231$572,5970.04%
WEDBUSH SECURITIES INC 42,414$1680.01%
Ancora Advisors LLC 78,373$311,1410.01%
Your Advocates Ltd., LLP 1,400$5,5580.00%
CRAWFORD INVESTMENT COUNSEL INC 32,098$127,4280.00%
Renaissance Technologies 273,663$1,0860.00%
GEODE CAPITAL MANAGEMENT, LLC 36,596$145,3500.00%
NORTHERN TRUST CORP 16,864$66,9500.00%
WELLS FARGO & COMPANY/MN 35$1380.00%
CALDWELL SUTTER CAPITAL, INC. 30$1190.00%
DIMENSIONAL FUND ADVISORS LP 38,184$151,5910.00%
MORGAN STANLEY 4,500$17,8650.00%
FMR LLC 100$3970.00%
Tower Research Capital LLC (TRC) 1,737$6,8960.00%
BlackRock Inc. 77,381$307,2030.00%
Capital Advisors, Ltd. LLC 60$00.00%
External links

This page lists PSYCHEMEDICS CORP's shareholders in Q3 2023. To view PSYCHEMEDICS CORP's shareholder history, click here.